Dea

The U.S. Department of Justice and the DEA issued a final order on April 23, 2026, moving FDA-approved cannabis drug products and state-licensed medical cannabis to Schedule III of the Controlled

Five days after the Department of Justice formally rescheduled state-licensed medical marijuana from Schedule I to Schedule III under the Controlled Substances Act, the Drug Enforcement